Lifecore Biomedical, Inc. said it will hold a special meeting on November 4, 2026, to discuss a merger.

Oct 20, 2026, 4:38 PM ETPaperworkRead the original at SEC EDGAR

Neutral

Setting the vote date moves the proposed merger process ahead. The vote is still pending, and this filing reports no new deal terms or business results.

LFCR · Lifecore Biomedical, Inc.

AI read · Neutral

The AI's read

This moves the proposed merger to a shareholder vote, but it does not show whether owners will approve it. The filing gives no new deal result or business performance, so it does not change how Lifecore's business looks.

Get alerts for LFCR

Follow Lifecore Biomedical, Inc. (LFCR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LFCR

Free on the App Store and Google Play, or on the web.